DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: As there are no effective treatments for dysferlinopathies, we assessed whether inhibition of the ubiquitin proteasome system could prevent degradation of dysferlin in immortalized myoblasts from a patient carrying two missense mutations.